Reduced inspiratory muscle strength increases pneumonia in patients with acute myocardial infarction

YiNing Dai1, Zhi Liu1, HuiMin Zhan1

  • 1Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510100, China.

Abstract

Insights

Inspiratory muscle weakness increases pneumonia risk in acute myocardial infarction (AMI) patients. Assessing maximal inspiratory pressure (MIP) can predict this risk, guiding potential interventions.

Area of Science:

  • Cardiology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Inspiratory muscle strength is linked to pneumonia post-surgery and in stroke patients.
  • Its association with pneumonia in acute myocardial infarction (AMI) patients remains unstudied.

Purpose of the Study:

  • To determine if inspiratory muscle strength predicts pneumonia in AMI patients.
  • Evaluate the diagnostic accuracy of maximal inspiratory pressure (MIP) for pneumonia risk.

Main Methods:

  • 265 AMI patients were enrolled and categorized into three groups based on MIP tertiles.
  • Maximal inspiratory pressure (MIP) was measured within 24 hours post-revascularization.
  • In-hospital pneumonia incidence was the primary outcome measure.

Main Results:

  • Pneumonia occurred in 10% of patients, with rates decreasing significantly across MIP tertiles (17% to 2%).
  • Reduced MIP was independently associated with a higher risk of pneumonia (OR 0.78).
  • MIP demonstrated good predictive performance for pneumonia (AUC 0.72).

Conclusions:

  • Inspiratory muscle weakness is a significant risk factor for pneumonia in AMI patients.
  • MIP is a valuable predictor of pneumonia, independent of mortality and MACEs.
  • Targeted inspiratory muscle training may benefit AMI patients at risk for pneumonia.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
557
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
463
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.9K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
553